The ABCC9/Sur2 gene is expressed in Ki67-positive cells and can be the target of drugs of therapeutic interest such as antidiabetic, cardiovascular, and anti-cancer drugs interfering with cell proliferation with drug–disease interactions. Here, ABCC9 is linked to cancer.